GlassScriptPhysician profile
Ronald S Labutti
NPI 1912980889
$6,011.80
in general payments reported to CMS, 2019-2025
14 companies · $600 in 2025
The $600 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,749 · 2020: $80.20 · 2021: $255 · 2022: $627 · 2023: $2,072 · 2024: $628 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680 · Travel and Lodging: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.97 |
| Travel and Lodging | $1,620.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $2,518.12 | 2023-2025 | Amistem, Gmk Revision, Gmk Sphere |
| Omnilife Science, INC | $1,641.46 | 2019-2021 | |
| Stryker Corporation | $783.42 | 2019-2022 | |
| Pacira Therapeutics, INC. | $225.00 | 2019-2021 | |
| Davol INC. | $207.00 | 2024 | Arista Ah Flexitip |
| Heraeus Medical, LLC. | $196.04 | 2025 | |
| Total Joint Orthopedics, INC. | $127.00 | 2024 | |
| Heron Therapeutics, INC. | $124.94 | 2024 | Aponvie, Zynrelef |
| Pacira Pharmaceuticals Incorporated | $38.88 | 2024-2025 | Zilretta, Iovera, Exparel |
| Polynovo North America LLC | $37.15 | 2023 | |
| Zimmer Biomet Holdings, INC. | $35.48 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $32.60 | 2025 | |
| Depuy Synthes Sales INC. | $26.05 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.66 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Labutti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.